Education
About Us
Working with TipRanks
Follow Us
Devonian Health Group, Inc. (TSE:GSD)
:GSD
GSD Stock Chart & Stats
C$0.18
--
Market closed
C$0.18
--
Day’s Range― - ―
52-Week RangeC$0.09 - C$0.25
Previous CloseN/A
VolumeN/A
Average Volume (3M)18.51K
Market Cap
C$31.53M
Enterprise ValueC$17.06M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.95
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding165,943,510
10 Day Avg. Volume26,400
30 Day Avg. Volume18,510
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Devonian Health Group News
GSD FAQ
What was Devonian Health Group, Inc.’s price range in the past 12 months?
Devonian Health Group, Inc. lowest stock price was C$0.09 and its highest was C$0.25 in the past 12 months.
What is Devonian Health Group, Inc.’s market cap?
Devonian Health Group, Inc.’s market cap is C$31.53M.
When is Devonian Health Group, Inc.’s upcoming earnings report date?
Devonian Health Group, Inc.’s upcoming earnings report date is Mar 26, 2026 which is in 90 days.
How were Devonian Health Group, Inc.’s earnings last quarter?
Devonian Health Group, Inc. released its earnings results on Dec 12, 2025. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Devonian Health Group, Inc. overvalued?
According to Wall Street analysts Devonian Health Group, Inc.’s price is currently Overvalued.
Does Devonian Health Group, Inc. pay dividends?
Devonian Health Group, Inc. does not currently pay dividends.
What is Devonian Health Group, Inc.’s EPS estimate?
Devonian Health Group, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Devonian Health Group, Inc. have?
Devonian Health Group, Inc. has 165,943,510 shares outstanding.
What happened to Devonian Health Group, Inc.’s price movement after its last earnings report?
Devonian Health Group, Inc. reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Devonian Health Group, Inc.?
Currently, no hedge funds are holding shares in TSE:GSD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Devonian Health Group, Inc.
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It is intended to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. The company's technology platform, The Supra Molecular Complex Extraction, and Stabilization Technology provide a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. The products of the group include botanical pharmaceuticals, Thykamine; and derma-cosmeceutical product, Purgenesis.
Technical Analysis
Rapid Dose Therapeutics Corp
―
BriaCell Therapeutics
―
Sirona Biochem
―
PharmaTher Holdings Ltd
―
Thiogenesis Therapeutics Corp
―